Xyntha Indications/Uses




Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
XYNTHA, Antihemophilic factor (Recombinant), is indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for: On-demand treatment and control of bleeding episodes; Perioperative management; Routine prophylaxis to reduce the frequency of bleeding episodes.
XYNTHA does not contain von Willebrand factor, and therefore is not indicated in patients with von Willebrand's disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in